Challenges in Combining Antiangiogenic Therapy With Transarterial Chemoembolization for Hepatocellular Carcinoma

BACKGROUND: The combination of systemic antiangiogenic therapy and transarterial chemoembolization (TACE) for the treatment of unresectable hepatocellular carcinoma (HCC) is the subject of several ongoing clinical trials. We present a series of patients treated with sorafenib and TACE at our institu...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Haydar, Ali A., Mukherji, Deborah, Faraj, Walid, Khalifeh, Mohammad, Taslakian, Bedros, Yehia, Zeinab Abou, Temraz, Sally, Brown, Karen T., Abou-Alfa, Ghassan K., Shamseddine, Ali
Формат: Artigo
Язык:Inglês
Опубликовано: International Society of Gastrointestinal Oncology 2014
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171975/
https://ncbi.nlm.nih.gov/pubmed/25276263
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы